| Trial ID: | L0654 |
| Source ID: | NCT01668901
|
| Associated Drug: |
Warfarin
|
| Title: |
Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Atrial Fibrillation|Chronic Kidney Disease
|
| Interventions: |
DRUG: warfarin|DRUG: Aspirin
|
| Outcome Measures: |
Primary: Thromboembolic event, Ischemis stroke and systemic thromboembolism, through study completion, an average of 1 year | Secondary: Major bleeding, through study completion, an average of 1 year
|
| Sponsor/Collaborators: |
Sponsor: Seoul National University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2012-09
|
| Completion Date: |
2016-06
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-25
|
| Locations: |
Seoul Nationap University Hospital, Seoul, 110-744, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01668901
|
